Aimovig Approved to Prevent Migraines

FRIDAY, May 18, 2018 — Aimovig (erenumab-aooe) has been approved by the U.S. Food and Drug Administration to prevent migraine headaches in adults.
Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by…
Source: Topamax